CORRECTION article

Front. Immunol., 20 March 2025

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1591209

Corrigendum: Targeting mitochondrial damage: shining a new light on immunotherapy

This article is a correction to:

  1. Targeting mitochondrial damage: shining a new light on immunotherapy

    1. Read original article
Wenjuan Zeng,&#x;Wenjuan Zeng1,2†Menghui Wang,&#x;Menghui Wang1,2†Yuxin ZhangYuxin Zhang3Taicheng Zhou*Taicheng Zhou4*Zhen Zong*Zhen Zong1*
  • 1Department of Gastrointestinal Surgery, The 2Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China
  • 2Huan Kui Academy, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China
  • 3The Second Clinical Medical College, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China
  • 4Department of Gastroenterological Surgery and Hernia Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangzhou, China

A Corrigendum on
Targeting mitochondrial damage: shining a new light on immunotherapy

by Zeng W, Wang M, Zhang Y, Zhou T and Zong Z (2024). Front. Immunol. 15:1432633. doi: 10.3389/fimmu.2024.1432633

In the published article, there was an error in Figure 1 as published. We have created a new Figure 1 and this new Figure provides a more detailed description of the mechanisms. The corrected Figure 1 and its caption: “The main mechanisms and characteristics of mitochondrial damage” appear below.

Figure 1
www.frontiersin.org

Figure 1. The main mechanisms and characteristics of mitochondrial damage.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: mitochondrial damage, immunotherapy, tumor microenvironment, target, immune cells

Citation: Zeng W, Wang M, Zhang Y, Zhou T and Zong Z (2025) Corrigendum: Targeting mitochondrial damage: shining a new light on immunotherapy. Front. Immunol. 16:1591209. doi: 10.3389/fimmu.2025.1591209

Received: 10 March 2025; Accepted: 13 March 2025;
Published: 20 March 2025.

Edited and Reviewed by:

Zong Sheng Guo, University at Buffalo, United States

Copyright © 2025 Zeng, Wang, Zhang, Zhou and Zong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Taicheng Zhou, WmhvdXRjaDNAbWFpbC5zeXN1LmVkdS5jbg==; Zhen Zong, bmRlZnkxNjEzM0BuY3UuZWR1LmNu

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.